Indian Scientists Develop ‘Smart’ Drug that Targets Cancer Cells
The experimental drug activates in high-ROS cancer cells and releases NBDHEX, a compound researchers say could limit damage to healthy tissue.
5 Articles
5 Articles
New pancreatic cancer drug that doubled survival time now reaching Charleston patients
It is one of the worst cancer diagnoses to get because pancreatic cancer is usually found after it has spread and surgery isn’t an option for many. A new targeted drug could help change that outlook.
New RK-251 Drug Targets Cancer Cells While Limiting Healthy Tissue Damage
Indian researchers have developed RK-251, a potential cancer treatment designed to activate mainly inside cancer cells. The drug was developed by researchers led by Dr. Asis Bala of IASST and Dr. K.P. Bhabak of IIT Guwahati. RK-251 works by responding to reactive oxygen species (ROS), which are found at higher levels in cancer cells. Once inside a cancer cell, these molecules activate RK-251 and release the anticancer compound NBDHEX. NBDHEX blo…
Indian scientists develop ‘smart’ drug that attacks cancer cells without harming healthy tissue - The Canadian Media
IBNS-CMEDIA: Indian scientists have developed a new “smart” cancer drug designed to activate primarily inside cancer cells, potentially offering a more targeted alternative to conventional chemotherapy, which can also damage healthy cells. Cancer treatments often affect healthy cells along with cancerous ones, resulting in significant adverse effects and side effects. This has created a growing
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
